- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/80 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 211/80
Total number of patents in this class: 27
10-year publication summary
|
4
|
4
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Les Laboratoires Servier | 496 |
3 |
| Vernalis (R&D) Limited | 123 |
3 |
| Hoffmann-La Roche Inc. | 3793 |
2 |
| LG Chem, Ltd. | 17921 |
2 |
| Novartis AG | 10262 |
1 |
| Boehringer Ingelheim International GmbH | 4493 |
1 |
| Bayer AG | 3501 |
1 |
| Vertex Pharmaceuticals Incorporated | 1582 |
1 |
| Alkahest, Inc. | 97 |
1 |
| Amira Pharmaceuticals, Inc. | 66 |
1 |
| BioMarin Pharmaceutical Inc. | 400 |
1 |
| Central South University | 489 |
1 |
| Centrexion Therapeutics Corporation | 65 |
1 |
| Commonwealth Scientific and Industrial Research Organisation | 1655 |
1 |
| INVISTA Technologies S.a.r.l. | 392 |
1 |
| Lipidart Kutato Fejleszto ES Tanacsado Kft. | 1 |
1 |
| NUtech Ventures | 365 |
1 |
| Ono Pharmaceutical Co., Ltd. | 421 |
1 |
| Promentis Pharmaceuticals, Inc. | 15 |
1 |
| UDC Ireland Limited | 508 |
1 |
| Other owners | 1 |